Pharma News

A new study reveals Feeling sad can impair our ability to accurately identify colors on the blue-yellow axis. The new research was published in the journal Psychological Science.

Glenmark Pharmaceuticals S.A., GBR 830, a novel monoclonal antibody has completed clinical phase 1 dosing. GBR 830 is an antagonist of OX40, a costimulatory receptor expressed on T cells mediating T cell activation and survival. Glenmark has now completed clinical phase I studies for GBR 830 in the Netherlands.

[adsense:336x280:8701650588]

Scientists have pinpointed a population of neurons in the brain that influences whether one drink leads to two and so on. The discovery could ultimately lead to a cure for alcoholism and other addictions, said researchers from the Texas A and M Health Science Center. They found that alcohol consumption alters the structure and function of neurons in the dorsomedial striatum, a part of the brain known to be important in goal-driven behaviors. The findings were published in the Journal of Neuroscience.

Researchers have identified a gene which may be associated with the initiation of NAFLD. The findings appeared in Translational Research.

Large numbers of people with learning disabilities are inappropriately prescribed strong psychiatric drugs, says a new research. The study is published online by The British Medical Journal.

The findings suggest that volatile anesthetics may someday be helpful for combating seasonal and pandemic influenza, particularly when there are flu vaccine shortages or limitations., says researchers, including an Indian-origin. The findings appeared in the journal Anesthesiology.

Amgen, a biopharmaceutical company, has entered a neuroscience collaboration with Novartis in the areas of Alzheimer's disease and migraine. The collaboration also enables Amgen to focus on the commercialisation of its migraine programmes in the US, Canada and Japan, while leveraging Novartis' strong commercial capabilities in neuroscience throughout Europe and other markets worldwide.

A new protein is being identified by researchers which regulates the severity of tissue damage caused by rheumatoid arthritis (RA), an autoimmune disease that causes inflammation, pain, stiffness and damage to the joints of the feet, hips, knees, and hands. The findings were detailed in the scientific journal PNAS.

A magnetic stimulation therapy for five sessions a week can help people afflicted with Parkinson's disease (PD) walk, new research has found. The study was published in the journal Restorative Neurology and Neuroscience.

BPL Medical Technologies Private Ltd announced the acquisition of Penlon Ltd, a UK-based leading global manufacturer of anaesthesia systems and vaporisers with worldwide distribution networks.